Department of Ophthalmology, Toronto Western Hospital, University of Toronto, Toronto, Ont.
Can J Ophthalmol. 2012 Jun;47(3):312-7. doi: 10.1016/j.jcjo.2012.03.040.
To assess the prognostic factors influencing visual prognosis and length of treatment after acanthamoeba keratitis (AK).
Forty-two AK eyes of 41 patients treated between 1999 and 2006 were included.
A diagnosis of AK was made on the basis of culture results with a corresponding clinical presentation. We calculated the prognostic effect of the various factors on final visual acuity and the length of treatment. Multivariate regression analysis was used to adjust for the simultaneous effects of the various prognostic factors.
Mean follow-up was 19.7 ± 21.0 months. Sixty-four percent of cases had > 1 identified risk factor for AK, the most common risk factor being contact lens wear (92.9% of eyes). At presentation, median best spectacle corrected visual acuity (BCVA) was 20/200 (20/30 to Hand Motion [HM]) that improved after treatment to 20/50 (20/20 to Counting Fingers [CF]). Infection acquired by swimming or related to contact lenses had significantly better final BCVA (p = 0.03 and p = 0.007, respectively). Neuritis and pseudodendrites were also associated with better final BCVA (p = 0.04 and p = 0.05, respectively). Having had an epithelial defect on presentation and having been treated with topical steroid were associated with worse final best spectacle corrected visual acuity (BSCVA) (p = 0.0006 and p = 0.04). Multivariate regression analysis found a good initial visual acuity (p = 0.002), infections related to swimming (p = 0.01), the absence of an epithelial defect (p = 0.03), having been treated with chlorhexidine (p = 0.05), and not having receive steroids (p = 0.003) to significantly forecast a good final BCVA.
We identified several prognostic factors that can help clinicians evaluate the expected visual damage of the AK infection and thus tailor treatment accordingly.
评估影响棘阿米巴角膜炎(AK)预后和治疗时间的预测因素。
纳入 1999 年至 2006 年间治疗的 41 例 42 只 AK 眼。
根据培养结果及相应的临床表现做出 AK 诊断。我们计算了各种因素对最终视力和治疗时间的预后影响。采用多变量回归分析调整各种预后因素的同时影响。
平均随访 19.7±21.0 个月。64%的病例有 1 个以上 AK 的危险因素,最常见的危险因素是隐形眼镜佩戴(92.9%的眼)。初诊时,最佳矫正视力(BCVA)中位数为 20/200(20/30 至 HM),治疗后提高至 20/50(20/20 至数手指)。因游泳或与隐形眼镜相关的感染获得的 AK 最终 BCVA 显著更好(p=0.03 和 p=0.007)。神经炎和假树突也与更好的最终 BCVA 相关(p=0.04 和 p=0.05)。初诊时有上皮缺损和局部使用皮质类固醇治疗与更差的最终最佳矫正视力(BSCVA)相关(p=0.0006 和 p=0.04)。多变量回归分析发现初始视力良好(p=0.002)、与游泳相关的感染(p=0.01)、无上皮缺损(p=0.03)、使用洗必泰治疗(p=0.05)和未使用皮质类固醇(p=0.003)显著预测 AK 最终有良好的 BCVA。
我们确定了一些预测因素,可帮助临床医生评估 AK 感染的预期视力损害,从而相应地调整治疗。